Stockreport

Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome [Yahoo! Finance]

Immunome, Inc.  (IMNM) 
PDF announced the completion of the previously announced sale of AL102, and related drug candidate AL101, to Immunome, Inc. (Nasdaq: IMNM). As per the terms of the sale, A [Read more]